Ryan Sides is an author at AZ Sint-Jan.
Publications per year
2018–2018
2
2
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Angelo Camporeale, David Kudrow, Ryan Sides et al. · BMC Neurology · 2018 · 140 citations · Full text
Rows per page
1–2 of 2